Non–FDG-Avid Primary Papillary Thyroid Carcinoma May Not Differ from FDG-Avid Papillary Thyroid Carcinoma

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Thyroid

• Publication date

  2013-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/thy.2013.0051PMID 23688271
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinicopathologic Characteristics of Synchronous Primary Thyroid Cancer Detected by Initial Staging 18F-FDG PET-CT Examination in Patients with Underlying Malignancy

  2013cited by this paper
• Characteristics of Primary Papillary Thyroid Carcinoma with False-Negative Findings on Initial 18F-FDG PET/CT

  2011influential reference
• The role of [18F]‐2‐fluoro‐2‐deoxy‐d‐glucose–positron emission tomography in thyroid nodules with indeterminate fine‐needle aspiration biopsy

  2011cited by this paper
• The role of [(18)F]-2-fluoro-2deoxy-d-dglucose-positron emission tomography in thyroid nodules iwht indeterminate fine-needle aspiration biopsy: sysematic review and meta-analysis of the literature

  2011cited by this paper
• Relationship Between Biological Marker Expression and Fluorine-18 Fluorodeoxyglucose Uptake in Incidentally Detected Thyroid Cancer

  2010cited by this paper
• HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.

  2010cited by this paper
• BRAFV600E mutation influences hypoxia-inducible factor-1α expression levels in papillary thyroid cancer

  2010cited by this paper
• Can calcification predict 131I accumulation on metastatic lymph nodes in papillary thyroid carcinoma patients receiving 131I therapy? Comparison of CT, 131I WBS and 18F-FDG PET/CT

  2010cited by this paper
• Pelvic lymph node F‐18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer

  2010cited by this paper
• Glut1 and Glut3 as Potential Prognostic Markers for Oral Squamous Cell Carcinoma

  2010cited by this paper
• Exclusion of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Aspiration Cytology After Negative 18F-Fluorodeoxyglucose Positron Emission Tomography: Interim Analysis

  2010cited by this paper
• Visually discernible [18F]fluorodeoxyglucose uptake in papillary thyroid microcarcinoma: a potential new risk factor.

  2010influential reference
• Relationship between primary lesion FDG uptake and clinical stage at PET-CT for non-small cell lung cancer patients: An observation.

  2010cited by this paper
• 18F‐FDG‐Uptake of Hepatocellular Carcinoma on PET Predicts Microvascular Tumor Invasion in Liver Transplant Patients

  2009cited by this paper
• Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer

  2009cited by this paper
• Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography

  2009influential reference
• Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

  2009cited by this paper
• Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors.

  2008cited by this paper
• Influence of Cell Proportions and Proliferation Rates on FDG Uptake in Squamous-Cell Esophageal Carcinoma: A PET Study

  2008cited by this paper
• 18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome

  2008cited by this paper
• Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI

  2008cited by this paper
• Imaging of tumor glucose utilization with positron emission tomography

  2008cited by this paper
• The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.

  2007influential reference
• Biological correlates of FDG uptake in non-small cell lung cancer.

  2007cited by this paper
• US Features of thyroid malignancy: pearls and pitfalls.

  2007cited by this paper
• The standardized uptake value for F‐18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival

  2007cited by this paper
• The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1α and GLUT-1 in non-small cell lung cancer

  2007cited by this paper
• Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.

  2006cited by this paper
• Expression of the GLUT1 glucose transporter, p63 and p53 in thyroid carcinomas.

  2006influential reference
• Can [18F]‐Fluorodeoxyglucose Standardized Uptake Values of PET Imaging Predict Pathologic Extrathyroid Invasion of Thyroid Papillary Microcarcinomas?

  2006influential reference
• Glucose metabolism and cancer.

  2006cited by this paper
• Correlation of GLUT-1 Overexpression, Tumor Size, and Depth of Invasion with 18F-2-fluoro-2-deoxy-d-glucose Uptake by Positron Emission Tomography in Colorectal Cancer

  2006cited by this paper
• Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning.

  2006cited by this paper
• Glucose transporter-1 expression in the thyroid gland: clinicopathological significance for papillary carcinoma.

  2005cited by this paper
• Normal FDG distribution patterns in the head and neck: PET/CT evaluation.

  2005cited by this paper
• Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer

  2005cited by this paper
• Preoperative evaluation of thyroid nodules with 18FDG-PET/CT.

  2005cited by this paper
• Biological characterisation of breast cancer by means of PET

  2004cited by this paper
• 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.

  2004cited by this paper
• Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin.

  2003cited by this paper
• Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects.

  2003cited by this paper
• Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.

  2002cited by this paper
• Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.

  2002cited by this paper
• Positron emission tomography in colorectal cancer.

  2002cited by this paper
• Glucose Transporter 1 Gene Expression is Related to Thyroid Neoplasms with an Unfavorable Prognosis: An Immunohistochemical Study

  2002cited by this paper
• Association of hypoxia‐inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinoma

  2002cited by this paper
• Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography

  2002cited by this paper
• Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer.

  2002cited by this paper
• Expression of glucose transporter‐1 in human gastric carcinoma

  2001cited by this paper
• Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

  2001cited by this paper
• The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages

  2000cited by this paper
• Recovery correction for quantitation in emission tomography: a feasibility study

  2000cited by this paper
• Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer.

  2000cited by this paper
• Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancer

  2000cited by this paper
• The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.

  2000cited by this paper
• Correlation of Glut-1 glucose transporter expression with.

  2000cited by this paper
• GLUT1 glucose transporter expression in colorectal carcinoma

  1998cited by this paper
• [Origin of cancer cells].

  1956cited by this paper
• On the origin of cancer cells.

  1956cited by this paper

• [18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules

  2022influential citation
• Metastatic Papillary Thyroid Cancer Mimicking Hypopharyngeal Carcinoma.

  2022cites this paper
• Multiparametric Photoacoustic Analysis of Human Thyroid Cancers In Vivo

  2021cites this paper
• Investigating 18F-FDG PET/CT Parameters as Prognostic Markers for Differentiated Thyroid Cancer: A Systematic Review

  2021cites this paper
• Hif-1α Inhibitors Could Successfully Inhibit the Progression of Differentiated Thyroid Cancer in Vitro

  2020cites this paper
• Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer

  2019influential citation
• Comparison of Natural Course between Thyroid Cancer Nodules and Thyroid Benign Nodules

  2019cites this paper
• Les carcinomes papillaires de la thyroïde révélés par examen TEP/TDM au 18F-FDG : à propos de deux cas et revue de la littérature

  2017cites this paper
• THE RELATIONSHIP OF BRAFV600E MUTATION STATUS TO FDG PET/CT AVIDITY IN THYROID CANCER: A REVIEW AND META-ANALYSIS.

  2017cites this paper
• Clinicopathological characteristics including BRAF V600E mutation status and PET/CT findings in papillary thyroid carcinoma

  2017cites this paper
• Association Between 18F-FDG Avidity and the BRAF Mutation in Papillary Thyroid Carcinoma

  2016cites this paper
• Multicompartment metabolism in papillary thyroid cancer

  2016cites this paper
• mutation and glucose metabolism in thyroid cancer patients : An 18 F-FDG-PET study

  2015cites this paper
• Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An 18F-FDG PET Study

  2015cites this paper
• Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study

  2014cites this paper